Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion type Assertion NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_head.
- NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion description "[Exon 20 PIK3CA mutations are relatively frequent in Her-2+ breast tumors and shorten survival, whereas neither exons 9 and 20 mutations seem related with ' triple negative ' breast carcinomas]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_provenance.
- NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion evidence source_evidence_literature NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_provenance.
- NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion SIO_000772 18679714 NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_provenance.
- NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion wasDerivedFrom lhgdn-20090331 NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_provenance.
- NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_assertion wasGeneratedBy ECO_0000203 NP163314.RAZVHfstlsCkvrXh0a_kSu-2DZ5y1h1I0Htr4WArPGNLw130_provenance.